HPV FOCAL Study

A clinical trial conducted within the BC Cervical Cancer Screening Program. HPV FOCAL evaluated the effectiveness and safety of HPV testing compared to the Pap test for cervical cancer prevention.

Principal Investigators: Dr. Gina Ogilvie, Dr. Andrew Coldman

Quadrivalent vaccine evaluation study (QUEST)

QUEST (Quadrivalent HPV Vaccine Evaluation Study) is a Canada-wide study designed to evaluate whether 2 doses of the HPV vaccine are just as effective as 3 doses at preventing Human Papillomavirus (HPV) infection and cervical cancer.

Principal Investigators: Drs. Gina Ogilvie, Simon Dobson

Long Term Follow-up Study of CTN 236 – A Study of an HPV VLP Vaccine in a Cohort of HIV Positive Girls and Women

This study aims to better understand how the HPV vaccine works in HIV positive girls and women over the long term and to clarify how care can be provided to best protect this population from HPV infection and associated cervical cancer and genital warts.

Principal Investigator: Dr. Deborah Money

CARMA-1-PREG

CARMA-1-PREG is investigating factors related to pre-term deliveries among HIV positive women.

Principal Investigator: Dr. Deborah Money

CARMA 7: Bone and Renal Outcomes in HIV-Exposed, Uninfected Infants with Perinatal Exposure to Tenofovir

The purpose of CARMA 7 is to investigate how fetal exposure to the anti-HIV medication Tenofovir may affect the bone and kidney health of infants who are born to HIV+ women.

Principle Investigator: Dr. Ariane Alimenti

Personalized Contraception for Canadians – Decision analytic modelling to support women-centered choices

Personalized Contraception for Canadians- Decision analytic modelling to support women-centered choices Principal Investigator: Dr. Flora Teng Primary Contact: Weihong Chen, Research Coordinator, 604-875-2424 x 4894, Weihong.chen@ubc.ca About the study: This study will develop and pilot test a Canadian woman-centered contraception decision-making mobile application. This app will be “effectiveness-based” and will incorporate factors women consider important when choosing […]

MIST (Mindfulness, Incontinence and Sexual function Treatment) Study Research Proposal for a Pilot Study

MIST (Mindfulness, Incontinence and Sexual function Treatment) Study Research Proposal for a Pilot Study Principal Investigators: Dr. Maryse Larouche/Dr. Geoffrey Cundiff Primary Contact: Nicole Koenig, Research Coordinator, 604-806-9829, nkoenig@providencehealth.bc.ca About the study: This study aims to determine if there is an impact on sexual distress using mindfulness-based sex therapy (MBST) in addition to standard urogynecologic care, in women […]

Mifepristone Implementation Research in Canada

Mifepristone implementation research in Canada – The CART-Mife Study Principal Investigator: Dr. Wendy Norman Primary Contact: Sarah Munro, Post-doctoral Fellow, 604-875-2424 ext 4990, Sarah.Munro@ubc.ca About the study: Mifepristone, approved by Health Canada, will be introduced in 2017. Currently 96% of Canadian abortions are surgical, largely concentrated in the largest cities close to the southern border. Overcoming […]

Canadian Sexual Health Survey Study

Canadian Sexual Health Survey Study Principal Investigators: Dr. Wendy Norman, Dr. Stirling Bryan Primary Contact: Eva McMillan, Research Coordinator, 604-875-2424 x 4871, eva.mcmillan@ubc.ca About the study: This study developed and validated the Canadian Sexual Health Survey (CSHS) that aimed to collect data on sexual and reproductive health among women aged 14-49 years throughout BC. The survey was then […]